Research Interests
The central research focus of the Tumor-Immune Interaction Lab (TIIL) is to study tumor-intrinsic resistance to immunotherapy. Leveraging cutting-edge technologies such as single-cell sequencing, spatial omics and imaging, digital pathology/pathomics, radiomics, and artificial intelligence, we identify novel therapeutic targets for drug repurposing, biomarkers for predicting therapy response, and model tumor-immune interactions using patient-derived organoids, enabling accelerated translation into clinical trials to improve patient outcomes.
Research Areas
Cancer
Faculty Website